Association between dosing and combination use of medications and outcomes in heart failure with reduced ejection fraction: data from the Swedish Heart Failure Registry

AIMS: To assess the association between combination, dose and use of current guideline‐recommended target doses (TD) of renin–angiotensin system inhibitors (RASi), angiotensin receptor–neprilysin inhibitors (ARNi) and β‐blockers, and outcomes in a large and unselected contemporary cohort of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Amario, Domenico, Rodolico, Daniele, Rosano, Giuseppe M.C., Dahlström, Ulf, Crea, Filippo, Lund, Lars H., Savarese, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2022
Materias:
Drug Therapy in Real‐world Practice
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315143/
https://www.ncbi.nlm.nih.gov/pubmed/35257446
http://dx.doi.org/10.1002/ejhf.2477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315143/
https://www.ncbi.nlm.nih.gov/pubmed/35257446
http://dx.doi.org/10.1002/ejhf.2477

Ejemplares similares